| Name | Title | Contact Details |
|---|---|---|
Tim Caffrey |
Senior Director of Finance | Profile |
James Detore |
Chief Financial Officer | Profile |
Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications. The company`s platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes to a broad range of cancers by binding selectively to peptide receptors that are selectively expressed on these tumors. This nonpeptide technology addresses many of the significant challenges currently facing peptide and protein targeted radiotherapeutics, particularly in the realm of optimizing drug-like characteristics and manufacturing. The company is rapidly advancing a pipeline of drug candidates to treat a broad range of cancers and is conducting additional drug discovery efforts to identify drug candidates for additional receptor targets in collaboration with Crinetics Pharmaceuticals.
Beckman Coulter Inc. is a Danaher Corporation company that develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing.
MaxThera, Inc. is a Beverly, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
The Heart of Healthtech Beats Here. We proudly serve as the voice of the #healthtech industry in New England, representing companies changing the world.
SCT helps New Jersey nursing homes improve care and reduce expenses by helping to better meet the phsycological needs of residents - at no cost to you